Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Organon & Co. (NY: OGN ) 20.35 +0.41 (+2.06%) Official Closing Price Updated: 7:00 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Organon & Co. < Previous 1 2 3 Next > Organon Publishes FY2022 ESG Report Showcasing Progress Toward Global Sustainability Goals June 27, 2023 From Organon & Co. Via Business Wire Organon and CAF, Development Bank of Latin America, Launch First-of-Its-Kind Collaboration to Increase Sustainable Financing in Women’s Health June 07, 2023 From Organon & Co. Via Business Wire Organon Reports Results for the First Quarter Ended March 31, 2023 May 04, 2023 From Organon & Co. Via Business Wire Organon To Report First Quarter and Host Conference Call on May 4, 2023 April 20, 2023 From Organon & Co. Via Business Wire Organon Launches “Her Plan is Her Power,” a New Global Initiative to Reduce Unplanned Pregnancies Where Need is Great and Disparities Exist March 07, 2023 From Organon & Co. Via Business Wire Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2022 February 16, 2023 From Organon Via Business Wire Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 16, 2023 February 06, 2023 From Organon & Co. Via Business Wire Organon Makes Strategic Investment in Claria Medical to Support Development of Investigational Medical Device for Minimally Invasive Hysterectomy January 05, 2023 From Organon & Co. Via Business Wire Organon To Present at the 41st Annual J.P. Morgan Healthcare Conference December 15, 2022 From Organon & Co. Via Business Wire Organon Appoints Kirke Weaver as General Counsel and Corporate Secretary December 12, 2022 From Organon & Co. Via Business Wire Organon To Present at the Piper Sandler 34th Annual Healthcare Conference November 15, 2022 From Organon & Co. Via Business Wire Organon Reports Results for the Third Quarter Ended September 30, 2022 November 03, 2022 From Organon & Co. Via Business Wire Organon To Report Third Quarter Results and Host Conference Call on November 3, 2022 October 20, 2022 From Organon & Co. Via Business Wire Samsung Bioepis and Organon Announce FDA Approval of Citrate-Free High-Concentration HUMIRA® Biosimilar HADLIMA™ (adalimumab-bwwd) August 17, 2022 From Organon & Co. Via Business Wire Organon Reports Results for the Second Quarter Ended June 30, 2022 August 04, 2022 From Organon & Co. Via Business Wire Organon and Cirqle Biomedical Enter Research Collaboration and License Agreement for Investigational Non-hormonal, On-demand Contraceptive Candidate July 28, 2022 From Organon & Co. Via Business Wire Organon To Report Second Quarter Results and Host Conference Call on August 4, 2022 July 21, 2022 From Organon & Co. Via Business Wire Organon Enters into Global License Agreement to Commercialize Henlius’ Investigational Perjeta® (Pertuzumab) and Prolia®/Xgeva® (Denosumab) Biosimilar Candidates June 13, 2022 From Organon & Co. Via Business Wire On One Year Anniversary, Organon Introduces Global ESG Strategy and Commitments with Publication of Inaugural ESG Report June 02, 2022 From Organon & Co. Via Business Wire Organon Reports Results for the First Quarter Ended March 31, 2022 May 05, 2022 From Organon & Co. Via Business Wire Organon To Report First Quarter Results and Host Conference Call on May 5, 2022 April 21, 2022 From Organon & Co. Via Business Wire Organon Enters into Global License Agreement to Commercialize Daré Bioscience’s XACIATO™ (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis (BV) March 31, 2022 From Organon & Co. Via Business Wire Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2021 February 17, 2022 From Organon & Co. Via Business Wire Organon Acquires Contraceptive Products, Marvelon® and Mercilon®, in the People’s Republic of China, including Hong Kong and Macau, and Agrees to Acquire these Products in Vietnam February 16, 2022 From Organon & Co. Via Business Wire Organon antaa koko henkilökunnalleen vapaapäivän oman terveytensä edistämiseksi kansainvälisenä naisten päivänä February 10, 2022 ”Koska Covid-19-pandemialla on edelleen suhteettoman suuri vaikutus naisiin, Organon kutsuu muita organisaatioita liittymään joukkoonsa ja olemaan Via EIN Presswire Organon Declares Paid Time Off for All Employees on International Women’s Day; Employees to Focus on Their Own Health in Recognition of Growing Women’s Health Inequity February 02, 2022 From Organon & Co. Via Business Wire Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 17, 2022 February 01, 2022 From Organon & Co. Via Business Wire FDA Accepts Samsung Bioepis’ and Organon’s sBLA for their Citrate-Free, High-Concentration HUMIRA® (Adalimumab) Biosimilar Candidate January 05, 2022 From Organon & Co. Via Business Wire Organon To Present at the 40th Annual J.P. Morgan Healthcare Virtual Conference December 20, 2021 From Organon & Co. Via Business Wire Organon Completes Acquisition of Forendo Pharma December 13, 2021 From Organon & Co. Via Business Wire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.